Orient Europharma Co Ltd (4120) — Cash Flow Quality Index
Orient Europharma Co Ltd (4120) has a Cash Flow Quality Index of 6.11x as of September 2024. Operating cash flow of NT$69.52 Million exceeds net income of NT$11.38 Million, indicating high earnings quality where cash backs reported profits. Explore Orient Europharma Co Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Orient Europharma Co Ltd Cash Flow Quality Index (2015–2023)
Historical Cash Flow Quality Index for Orient Europharma Co Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 4120 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Orient Europharma Co Ltd (2015–2023)
Year-by-year earnings quality comparison for Orient Europharma Co Ltd. For live market cap and the full company financial profile, see Orient Europharma Co Ltd market cap and net worth.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 0.45x | NT$64.67 Million | NT$143.94 Million | ▼ -30.5% |
| 2021 | 0.65x | NT$77.65 Million | NT$120.17 Million | ▼ -78.8% |
| 2020 | 3.05x | NT$608.55 Million | NT$199.30 Million | ▲ +232.6% |
| 2019 | 0.92x | NT$227.37 Million | NT$247.66 Million | ▼ -2.1% |
| 2018 | 0.94x | NT$231.31 Million | NT$246.74 Million | ▼ -28.5% |
| 2017 | 1.31x | NT$601.08 Million | NT$458.73 Million | ▲ +453.2% |
| 2016 | 0.24x | NT$111.24 Million | NT$469.61 Million | ▼ -91.8% |
| 2015 | 2.89x | NT$643.97 Million | NT$223.16 Million | — |